paroxetine

(redirected from Paxil cr)
Also found in: Medical.

par·ox·e·tine

 (pă-rŏk′sĭ-tēn′)
n.
A drug of the SSRI class, C19H20FNO3, used in its hydrochloride form to treat depression, anxiety, and certain other disorders, including obsessive-compulsive disorder.

[par(a)- + ox(y)- + (m)et(hyl) + (piperid)ine.]

paroxetine

(pæˈrɒksətiːn)
n
(Pharmacology) an antidepressant drug that acts by preventing the re-uptake after release of serotonin in the brain, thereby prolonging its action: used for treating depression, obsessive-compulsive disorders, and panic disorder. Formula: C19H20FNO3
Translations

paroxetine

n paroxetina
Mentioned in ?
References in periodicals archive ?
Prior to this, Parada worked on direct-to-consumer advertising for major pharmaceutical brands like Benadryl, Lunesta and Paxil CR at New York agencies J.
Ortiz said the company allowed several drugs to be adulterated between 2001 and 2005, including Paxil CR, a skin-infection ointment called Bactroban, an anti-nausea drug called Kytril, and a diabetes drug called Avandamet.
Cheap copies of the antidepressant Paxil CR and another four products cut pounds 450m from Glaxo's first-quarter sales, the company said last month.
Cheaper copies of the antidepressant Paxil CR and another four products trimmed 450 million pounds from sales compared with the same quarter a year earlier, Witty said.
Dr Senior said other issues were more worrying, including the decision by GlaxoSmithKline not to defend patents covering its anti- depressant Paxil CR, making generic competition more likely in the second half of next year.
The firm recently reintroduced anti-depressant Paxil CR after it was withdrawn amid fears over its quality - but analyst Jeremy Batstone at stockbroker Charles Stanley said its return came too late to affect Thursday's interim results.
The company's stock fell sharply in March when the Food and Drug Administration (FDA) forced it to withdraw antidepressant Paxil CR and its Avandamet diabetes treatment amid concerns they were of poor quality.
SkyePharma has a partnership with GlaxoSmithKline for marketing depression drug Paxil CR and is developing new versions of drugs including AstraZeneca's Pulmicort and GlaxoSmithKline's Requip.
According to Mylan, it has an exclusive license to an Orange Book patent pertaining to Paxil CR which expires in July 2016, with pediatric exclusivity extending until January 19, 2017.
The drugs, manufactured in Puerto Rico between 2001 and 2005, included the antinausea drug Kytril, the antidepressant Paxil CR, the diabetes medication Avandamet, and the anti-infection ointment Bactroban.
The procedures were implemented as part of a consent decree with the FDA that was signed last year by GSK after the company was cited for manufacturing deficiencies associated with Paxil CR (paroxetine) and Avandamet (rosiglitazone and metformin), which are produced at the same Cidra, Puerto Rico, manufacturing facility that makes Coreg.
Glaxo, which employs 2,200 people at Barnard Castle in County Durham and Ulverston in Cumbria, said sales in the US would have grown 7% from April to June rather than 3% had federal authorities not forced it to halt supplies of Paxil CR last March.